Financials
Financial year 2025
Gross margin
€ 1.5 million
▲ 3% vs 2024
Profit
Healthy€ 23,980
▼ 80% vs 2024
Debts
Normal€ 4.1 million
▲ 18% vs 2024
HEMOTECH BELUX from Koekelare, company number BE0474412845, closed financial year 2025 with a result of € 23,980 after tax. For that financial year HEMOTECH BELUX recorded a gross margin of € 1.5 million and equity of € 859,416. Compared with financial year 2024, the result moved from € 118,944 to € 23,980. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
What happened at HEMOTECH BELUX?
What happened at HEMOTECH BELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 23,980 (▼ 80% vs 2024). Source: NBB ↗
- POLLET MEDICAL GROUP NV became a director. NBB
- Smardix Besloten Vennootschap became a director. NBB
- Linus BV became a director. NBB
- New establishment in Mechelen. KBO
- VDW Consults BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 34,880 loss in 2021 to € 23,980 profit in 2025.
Paid € 93,940 in corporate taxes since 2021.
Best year ever: 2024, with € 118,944 profit.
On average € 138,500 of value added per employee in 2025.
A new publication or filing at HEMOTECH BELUX? We notify you, reason included.
Follow HEMOTECH BELUXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind HEMOTECH BELUX are VDW Consults BV, POLLET MEDICAL GROUP NV, Smardix Besloten Vennootschap and Linus BV. The same people are also behind TERBASSENWEI, STERIMA, Sterima Medical & Logistic Services Liège, Integrated Service Solutions Hospitals and EURAQUA-EUROPE.
Directors
According to the 2025 annual accounts
Director · represented by Mats Vandeweeghde
since 2021
Voorzitter van het Bestuursorgaan · represented by Sofie POLLET
Also active at: TERBASSENWEI, STERIMA, Sterima Medical & Logistic Services Liège +1 more
since 2024
Director · represented by Taillieu Dimitri
Also active at: TERBASSENWEI, STERIMA, EURAQUA-EUROPE +19 more
since 2024
since 2022
Establishments
Establishment units
Physical locations of this company
Brouwerijstraat 14
8680 Koekelare
Blarenberglaan 21
2800 Mechelen
Active since 1 June 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
TERBASSENWEI same network
€ 3 million gross margin · 2025
UNIMID same network
€ -249,093 gross margin · 2025
PPG Belgium same network
€ 33.4 million revenue · 2025
ALTRANS same network
€ 824,938 gross margin · 2025
POLLET GROUP same network
€ 7.8 million revenue · 2025
+12 more
Details
- Company number
- 0474.412.845
- VAT number
- BE 0474.412.845
- Registered office
- Brouwerijstraat 14, 8680 Koekelare
- Names & denominations
- HEMOTECH BELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 March 2001
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering